Northwestern Mutual Wealth Management Company »

Brainstorm Cell Therapeutics shares owned by Northwestern Mutual Wealth Management Company

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics shares owned by Northwestern Mutual Wealth Management Company from 13F filings

Historical chart of Northwestern Mutual Wealth Management Company investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by Northwestern Mutual Wealth Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by Northwestern Mutual Wealth Management Company

Quarter filed Position value Share count Share price at filing
2024-09-30 $36 161 0.23
2024-06-30 $54 161 0.34

More positions owned by Northwestern Mutual Wealth Management Company

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core S&p Mcp Etf (IJH)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Ishares Tr Core S&p Scp Etf (IJR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Value (VLUE)
Ishares Msci Eurzone Etf (EZU)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Northwestern Mutual Wealth Management Company

Top funds holding Brainstorm Cell Therapeutics

Geode Capital Management
BlackRock
Liberty Wealth Management
Weaver Consulting Group
Susquehanna International
Northern Trust
Raymond James & Associates
Jmac Enterprises
Wells Fargo & Company
Group One Trading
Tru Independence Asset Management 2
Citadel Advisors
Janney Montgomery Scott
Creative Planning
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics